Risk factors for hepatitis C virus reinfection after sustained virologic response in patients coinfected with HIV
J Young, C Rossi, J Gill, S Walmsley… - Clinical Infectious …, 2017 - academic.oup.com
Background. Highly effective hepatitis C virus (HCV) therapies have spurred a scale-up of
treatment to populations at greater risk of reinfection after sustained virologic response …
treatment to populations at greater risk of reinfection after sustained virologic response …
Disparities in direct acting antivirals uptake in HIV‐hepatitis C co‐infected populations in Canada
Background Direct acting antivirals (DAA s) have revolutionized hepatitis C (HCV) treatment
with> 90% cure rates even in real‐world studies, giving hope that HCV can be eliminated …
with> 90% cure rates even in real‐world studies, giving hope that HCV can be eliminated …
How generalizable are the results from trials of direct antiviral agents to people coinfected with HIV/HCV in the real world?
Abstract Background. Direct-acting antivirals (DAAs) against hepatitis C virus (HCV) have
been described as revolutionary. However, it remains uncertain how effective these drugs …
been described as revolutionary. However, it remains uncertain how effective these drugs …
Assessment of treatment strategies to achieve hepatitis C elimination in Canada using a validated model
Importance Achievement of the World Health Organization (WHO) target of eliminating
hepatitis C virus (HCV) by 2030 will require an increase in key services, including harm …
hepatitis C virus (HCV) by 2030 will require an increase in key services, including harm …
Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIV
Objective (s): To evaluate changes in injecting and sexual risk behaviours, and hepatitis C
virus (HCV) reinfection incidence among people with HIV/HCV coinfection following …
virus (HCV) reinfection incidence among people with HIV/HCV coinfection following …
[HTML][HTML] Real-world efficacy of daclatasvir and sofosbuvir, with and without ribavirin, in HIV/HCV coinfected patients with advanced liver disease in a French early …
K Lacombe, H Fontaine, C Dhiver… - JAIDS Journal of …, 2017 - journals.lww.com
Background: Efficacious, well-tolerated, direct antiviral agents have drastically changed the
prognosis of hepatitis C virus (HCV) disease, but real-world data for oral treatments are …
prognosis of hepatitis C virus (HCV) disease, but real-world data for oral treatments are …
Daclatasvir plus sofosbuvir, with or without ribavirin, in real-world patients with HIV–HCV coinfection and advanced liver disease
JK Rockstroh, P Ingiliz, J Petersen… - Antiviral …, 2017 - journals.sagepub.com
Background HIV–HCV-coinfected patients respond just as well to modern direct-acting
antiviral HCV therapy as HCV-monoinfected patients. However, clinical data for all-oral HCV …
antiviral HCV therapy as HCV-monoinfected patients. However, clinical data for all-oral HCV …
Variation in hepatitis C virus treatment uptake between Canadian centres in the era of direct-acting antivirals
Background Patients co-infected with HIV and hepatitis C virus (HCV) are a priority target for
HCV treatment. The simplicity and efficacy of direct-acting antivirals (DAA) should help …
HCV treatment. The simplicity and efficacy of direct-acting antivirals (DAA) should help …
Patterns of practice and barriers to care for hepatitis C in the direct-acting antiviral (DAA) era: a national survey of Canadian infectious diseases physicians
Background: Infectious diseases (ID) physicians are important for hepatitis C virus (HCV)
care delivery in Canada. Our study describes their current and intended patterns of practice …
care delivery in Canada. Our study describes their current and intended patterns of practice …
[HTML][HTML] Hepatitis C treatment initiation in HIV-HCV coinfected patients
Background There are few data regarding HCV treatment initiation among HIV/HCV
coinfected patients. The objective of this study was to analyze the changing patterns of HCV …
coinfected patients. The objective of this study was to analyze the changing patterns of HCV …